WHO ICTRP trial
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for…
CTIS2025-522400-24-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2025-522400-24-00 |
|---|---|
| Public title | Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer with Disease Progression on or After Immunotherapy |
| Scientific title | IZABRIGHT-BLADDER01: A Randomized, Open-label, Phase 2/3 trial of Izalontamab Brengitecan versus platinum-based chemotherapy for metastatic urothelial cancer in participants with disease progression on or after an immunotherapy-based treatment - CA2440012 |
| Primary sponsor | Bristol-Myers Squibb Services Unlimited Company |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): No |
| Countries | Argentina;Brazil;Canada;Switzerland;China;Korea, Republic of;United States;United Kingdom;Australia;Japan;Israel;Austria;Belgium;France;Germany;Ireland;Italy;Romania;Spain;Sweden;Norway |
| Conditions | Metastatic urothelial cancer MedDRA version: 27.0Level: LLTClassification code: 10090000Term: Urothelial carcinoma metastatic Class: 100000004864;Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications… |
| Interventions | Product Name: PEGFILGRASTIM, Product Code:SUB16451MIG, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: CARBOPLATIN, Product Code:SUB06614MIG, Pharmaceutical Form: CONCENTRATE FOR SOLUTION FOR… |
| Registration date | Aug 29, 2025 |
| Target size | 452 |
| Secondary IDs | U1111-1322-9071 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: